Blizzards and user fees
This article was originally published in The Gray Sheet
FDA said it will extend congressionally-mandated decision deadlines for devices and drugs whose Medical Device User Fee Act (MDUFA) or Prescription Drug User Fee Act (PDUFA) decision goals came due during or shortly after the extreme winter storms that swept through Washington, D.C., and shut down FDA offices earlier this month. FDA is extending the deadline for user fee decisions due the weeks of Feb. 8 and Feb. 15 by up to four business days for devices and five business days for drugs. Further, product submissions that would normally have been received during the closure will not be marked as "received," for purposes of starting the regulatory clock, until the FDA center resumes normal operations
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.